John Neis's Net Worth
-$37.2 Thousand
Who is John Neis?
John Neis does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include THIRD WAVE TECHNOLOGIES INC /WI, TomoTherapy Inc, Akebia Therapeutics, Inc., and Cellectar Biosciences, Inc..
SEC CIK
John Neis's CIK is 0001167426
Past Insider Trading and Trends
2005 was John Neis's most active year for acquiring shares with 4 total transactions. John Neis's most active month to acquire stocks was the month of May. 2021 was John Neis's most active year for disposing of shares, totalling 5 transactions. John Neis's most active month to dispose stocks was the month of February. 2005 saw John Neis paying a total of $37,241.00 for 10,000 shares, this is the most they've acquired in one year. In 2021 John Neis cashed out on 234,742 shares for a total of $67,151.29, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
THIRD WAVE TECHNOLOGIES INC /WI No price found
InvestorJohn Neis owns 74,375 units of Common Stock.acquired a total of 10,000 shares in THIRD WAVE TECHNOLOGIES INC /WI at a cost of $37,241.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
| +7.21% | 5K |
$2.68 | $13,391.00 | 74.38K |
Nov 8
| |||
Form 4
| +10.17% | 5K |
$4.77 | $23,850.00 | 54.17K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
| No matching records found | |||||||||
TomoTherapy Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.18% | -125.00K |
$13.23 | -$1,654,182.50 | 823.64K |
Mar 12 - Mar 14
| |||
Form 4
| -19.50% | -792.62K |
$14.53 | -$501,948.68 | 3.27M |
Feb 26
| |||
Form 4
| -30.26% | -1.76M |
$22.25 | -$39,240,189.00 | 4.06M |
Oct 16
| |||
Form 4
| -11.30% | -742.42K |
$19.00 | -$14,106,056.00 | 5.83M |
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.36
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cellectar Biosciences, Inc. (CLRB) Snapshot price: $2.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17 - Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12 - Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 12
| |||
Form 4
| -0.83% | -5.21K |
$1.49 | -$7,790.76 | 626.1K |
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +111.86% | 333.33K |
$1.49 | $496,666.17 | 631.32K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
| +371.18% | 234.74K |
$2.12 | $497,653.04 | 297.98K |
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +73.88% | 268.71K |
$3.75 | $1,007,666.25 | 632.43K |
Aug 20
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||